Transformed PANSS Factors Intended to Reduce Pseudospecificity Among Symptom Domains and Enhance Understanding of Symptom Change in Antipsychotic-Treated Patients With Schizophreni...

por Hopkins, Seth C, Ogirala, Ajay, Loebel, Antony, Koblan, Kenneth S
Publicado 2018

Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERS

por Hopkins, Seth C., Ogirala, Ajay, Worden, MaryAlice, Koblan, Kenneth S.
Publicado 2021

Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D(2)-Based Pharmacological Class Effect Query Defined by FAERS

por Hopkins, Seth C., Ogirala, Ajay, Zeni, Courtney, Worden, MaryAlice, Koblan, Kenneth S.
Publicado 2022